Skip to content

Clinical trials

Phase 3 Bronchiolitis Obliterans Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 3 Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20092
20102
20112
20122
20132
20142
20154
20161
20174
20201
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Active, not recruiting3
Recruiting3
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
Gilead Sciences3
Incyte Corporation3
APT Pharmaceuticals, Inc.2
Pharmacyclics LLC.2
AbbVie1
AstraZeneca1
Bausch Health Americas, Inc.1
Dompé Farmaceutici S.p.A1
Genzyme, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome29
Lymphoma, Follicular5
Hepatitis C4
Psoriasis4
Bronchiolitis Obliterans3
Graft vs Host Disease3
Pruritus3
Leukemia2
Leukemia, Lymphocytic, Chronic, B-Cell2
Acquired Immunodeficiency Syndrome1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.